Supporting this, gut CD4 T-cells from anti-TNF-α-treated IBD patients show lower amounts of IL-22BP but still express IL-22 [220] and may even up-regulate IL-22 generation [230]. The gene discussed is CD4; the disease is inflammatory bowel disease.